Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (CSF), but Not Recombinant Human Granulocyte CSF, Down-Regulates the Recombinant Human Stem Cell Factor-Dependent Differentiation of Human Fetal Liver-Derived Mast Cells

Journal of Immunology

Volumn 159, Issue 2, 1997, Pages 838-845

  Du, Zhongmin ^a   Li, Yongli ^a   Xia, Hanzhang ^a   Irani, Anne Marie ^a   Schwartz, Lawrence B ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STEM CELL FACTOR;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; DRUG INTERACTION; FEMALE; HUMAN; LIVER; MAST CELL; PREGNANCY; PRENATAL DEVELOPMENT;

CELL DIFFERENTIATION; CELLS, CULTURED; DOWN-REGULATION; DRUG INTERACTIONS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LIVER; MAST CELLS; PREGNANCY; STEM CELL FACTOR;

EID: 0031570933     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Valent, P., E. Spanblöchl, W. R. Sperr, C. Sillaber, K. M. Zsebo, H. Agis, H. Strobl, K. Geissler, P. Bettelheim, and K. Lechner. 1992. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood 80:2237.
2. Irani, A. A., G. Nilsson, U. Miettinen, S. C. Craig, L. K. Ashman, T. Ishizaka, K. M. Zsebo, and L. B. Schwartz. 1992. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 80:3009.
3. Mitsui, H., T. Furitsu, A. M. Dvorak, A. A. Irani, L. B. Schwartz, N. Inagaki, M. Takei, K. Ishizaka, K. M. Zsebo, S. Gillis, and T. Ishizaka. 1993. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc. Natl. Acad. Sci. USA 90:735.
4. Tsai, M., T. Takeishi, H. Thompson, K. E. Langley, K. M. Zsebo, D. D. Metcalfe, E. N. Geissler, and S. J. Galli. 1991. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc. Natl. Acad. Sci. USA 88:6382.
5. 2 from cord blood mononuclear cells. J. Immunol. 157:343.
6. Nakahata, T., K. Tsuji, R. Tanaka, K. Muraoka, N. Okumura, N. Sawai, M. Takagi, S. Itoh, C. Ra, and H. Saito. 1995. Synergy of stem cell factor and other cytokines in mast cell development. In Biological and Molecular Aspects of Mast Cell and Basophil Differentiation and Function. Y. Kitamura, S. Yamamodo, S. J. Galli, and M. W. Greaves, eds. Raven Press, New York, p. 13.
7. Nilsson, G., U. Miettinen, T. Ishizaka, L. K. Ashman, A.-M. Irani, and L. B. Schwartz. 1994. Interleukin-4 inhibits the expression of Kit and tryptase during stem cell factor-dependent development of human mast cells from fetal liver cells. Blood 84:1519.
8. Sillaber, C., W. R. Sperr, H. Agis, E. Spanblöchl, K. Lechner, and P. Valent. 1994. Inhibition of stem cell factor dependent formation of human mast cells by interleukin-3 and interleukin-4. Int. Arch. Allergy Immunol. 105:264.
9. Irani, A. A., G. Nilsson, L. K. Ashman, and L. B. Schwartz. 1995. Dexamethasone inhibits the development of mast cells from dispersed human fetal liver cells cultured in the presence of recombinant human stem cell factor. Immunology 84:72.
10. Ihle, J. N., J. R. Keller, S. Oroszlan, L. E. Henderson, T. D. Copeland, F. W. Fitch, M. B. Prystowsky, E. Goldwasser, J. W. Schrader, E. W. Palaszynski, M. Dy, and B. Lebel. 1983. Biologic properties of homogeneous inlerleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity. J. Immunol. 131:282.
11. Valent, P., J. Besemer, C. Sillaber, J. H. Butterfield, R. Eher, O. Majdic, K. Kishi, W. Klepetko, F. Eckersberger, K. Lechner, and P. Bettelheim. 1990. Failure to detect IL-3-binding sites on human mast cells. J. Immunol. 145:3432.
12. Kirshenbaum, A. S., J. P. Goff, S. C. Dreskin, A. A. Irani, L. B. Schwartz, and D. D. Metcalfe. 1989. IL-3-dependent growth of basophil-like cells and mast-like cells from human bone marrow. J. Immunol. 142:2424.
13. + pluripotent progenitor cells. J. Immunol. 148:772.
14. Takaue, Y., Y. Kawano, C. L. Reading, T. Watanabe, T. Abe, T. Ninomiya, E. Shimizu, T. Ogura, Y. Kuroda, A. Yokobayashi, T. Nakahata, S. Asano, and G. Ventura. 1990. Effects of recombinant human G-CSF, GM-CSF, IL-3, and IL-1α on the growth of purified human peripheral blood progenitors. Blood 76: 330.
15. McNiece, I. K., K. E. Langley, and K. M. Zsebo. 1991. Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp. Hematol. 19:226.
16. Xiao, M., T. Leemhuis, H. E. Broxmeyer, and L. Lu. 1992. Influence of combinations of cytokines on proliferation of isolated single cell-sorted human bone marrow hematopotetic progenitor cells in the absence and presence of serum. Exp. Hematol. 20:276.
17. Louis, R., A. Dowlati, T. Weber, T. Bury, J. L. Corhay, and M. F. Radermecker. 1994. Modulation of immunological histamine release from human lung fragments by stem cell factor, IL-3, IL-5 and GM-CSF: comparison with human leukocytes. Int. Arch. Allergy Immunol. 105:18.
18. Tomioka, K., D. W. MacGlashan, Jr., L. M. Lichtenstein, B. S. Bochner, and R. P. Schleimer. 1993. GM-CSF regulates human eosinophil responses to F-Met peptide and platelet activating factor. J. Immunol. 151:4989.
19. Tanimoto, Y., K. Takahashi, and I. Kimura. 1992. Effects of cytokines on human basophil chemotaxis. Clin. Exp. Allergy 22:1020.
20. Yamaguchi, M., K. Hirai, Y. Morita, T. Takaishi, K. Ohta, S. Suzuki, K. Motoyoshi, O. Kawanami, and K. Ito. 1992. Hemopoietic growth factors regulate the survival of human basophils in vitro. Int. Arch. Allergy Appl. Immunol. 97:322.
21. Her, E., J. Frazer, K. F. Austen, and W. F. Owen, Jr. 1991. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils: cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. J. Clin. Invest. 88:1982.
22. Haak-Frendscho, M., N. Arai, K. Arai, M. L. Baeza, A. Finn, and A. P. Kaplan. 1988. Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release. J. Clin. Invest. 82:17.
23. Hirai, K., Y. Morita, Y. Misaki, K. Ohta, T. Takaishi, S. Suzuki, K. Motoyoshi, and T. Miyamoto. 1988. Modulation of human basophil histamine release by hemopoietic growth factors. J. Immunol. 141:3958.
24. Bischoff, S. C., A. L. De Weck, and C. A. Dahinden. 1990. Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a. Proc. Natl. Acad. Sci. USA 87:6813.
25. Fujisawa, T., R. Abu-Ghazaleh, H. Kita, C. J. Sanderson, and G. J. Gleich. 1990. Regulatory effect of cytokines on eosinophil degranulation. J. Immunol. 144:642.
26. 4 in response to FMLP. J. Clin. Invest. 87:1958.
27. Tsuda, T., D. Wong, J. Dolovich, J. Bienenstock, J. Marshall, and J. A. Denburg. 1991. Synergistic effects of nerve growth factor and granulocyte-macrophage colony-stimulating factor on human basophilic cell differentiation. Blood 77:971.
28. Levi-Schaffer, F., P. Lacy, N. J. Severs, T. M. Newman, J. North, B. Gomperts, A. B. Kay, and R. Moqbel. 1995. Association of granulocyte-macrophage colony-stimulating factor with the crystalloid granules of human eosinophils. Blood 85: 2579.
29. Boyce, J. A., D. Friend, M. F. Gurish, K. F. Austen, and W. F. Owen. 1996. Constitutive production of granulocyte macrophage colony-stimulating factor by hypodense mononuclear eosinophils developed in vitro from hybrid eosinophil basophil granulocytes. Proc. Natl. Acad. Sci. USA 93:2436.
30. Subauste, M. C., D. B. Jacoby, S. M. Richards, and D. Proud. 1995. Infection of a human respiratory epithelial cell line with rhinovirus: induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J. Clin. Invest. 96:549.
31. Plaut, M., J. H. Pierce, C. J. Watson, J. Hanley-Hyde, R. P. Nordan, and W. E. Paul. 1989. Mast cell lines produce lymphokines in response to cross-linkage of FcRI or to calcium ionophores. Nature 339:64.
32. Arock, M., C. Zuany-Amorim, M. Singer, M. Benhamou, and M. Pretolani. 1996. Interleukin-10 inhibits cytokine generation from mast cells. Eur. J. Immunol. 26:166.
33. Wodnar-Filipowicz, A., C. H. Heusser, and C. Moroni. 1989. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature 339:150.
34. Keegan, A. D., J. H. Pierce, J. Artrip, M. Plaut, and W. E. Paul. 1991. Ligand stimulation of transfected and endogenous growth factor receptors enhances cytokine production by mast cells. EMBO J. 10:3675.
35. Nilsson, G., V. Svensson, and K. Nilsson. 1995. Constitutive and inducible cytokine mRNA expression in the human mast cell line HMC-1. Scand. J. Immunol. 42:76.
36. Massey, W., B. Friedman, M. Kato, P. Cooper, A. Kagey-Sobotka, L. M. Lichtenstein, and R. P. Schleimer. 1993. Appearance of granulocyte-macrophage colony-stimulating factor activity at allergen-challenged cutaneous late-phase reaction sites. J. Immunol. 150:1084.
37. Ohnishi, T., H. Kita, A. N. Mayeno, S. Okada, S. Sur, D. H. Broide, and G. J. Gleich. 1996. Lidocaine in bronchoalveolar lavage fluid (BALF) is an inhibitor of eosinophil-active cytokines. Clin. Exp. Immunol. 104:325.
38. Broide, D. H., M. Lotz, A. J. Cuomo, D. A. Coburn, E. C. Federman, and S. I. Wasserman. 1992. Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol. 89:958.
39. Broide, D. H., M. M. Paine, and G. S. Firestein. 1992. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J. Clin. Invest. 90:1414.
40. Broide, D. H., and G. S. Firestein. 1991. Endobronchial allergen challenge in asthma: demonstration of cellular source of granulocyte macrophage colony-stimulating factor by in situ hybridization. J. Clin. Invest. 88:1048.
41. Ohtoshi, T., T. Tsuda, C. Vancheri, J. S. Abrams, J. Gauldie, J. Dolovich, J. A. Denburg, and M. Jordana. 1991. Human upper airway epithelial cell-derived granulocyte-macrophage colony-stimulating factor induces histamine-containing cell differentiation of human progenitor cells. Int. Arch. Allergy Appl. Immunol. 95:376.
42. Dranoff, G., A. D. Crawford, M. Sadelain, B. Ream, A. Rashid, R. T. Bronson, G. R. Dickersin, C. J. Bachurski, E. L. Mark, J. A. Whitsett, and R. C. Mulligan. 1994. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264:713.
43. Lieschke, G. J., D. Grail, G. Hodgson, D. Metcalf, E. Stanley, C. Cheers, K. J. Fowler, S. Basu, Y. F. Zhan, and A. R. Dunn. 1994. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84:1737.
44. Dong, F., L. H. Hoefsloot, A. M. Schelen, C. A. Brooders, Y. Meijer, A. J. Veerman, I. P. Touw, and B. Lowenberg. 1994. Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia. Proc. Natl. Acad. Sci. USA 91:4480.
45. Pluznik, D. H., R. E. Cunningham, and P. D. Noguchi. 1984. Colony-stimulating factor (CSF) controls proliferation of CSF-dependent cells by acting during the G1 phase of the cell cycle. Proc. Natl. Acad. Sci. USA 81:7451.
46. Bressler, R. B., H. L. Thompson, J. M. Keffer, and D. D. Metcalfe. 1989. Inhibition of the growth of IL-3-dependent mast cells from murine bone marrow by recombinant granulocyte macrophage-colony-stimulating factor. J. Immunol. 143:135.
47. Rottem, M., G. Hull, and D. D. Metcalfe. 1994. Demonstration of differential effects of cytokines on mast cells derived from murine bone marrow and peripheral blood mononuclear cells. Exp. Hematol. 22:1147.
48. 2 from cord blood mononuclear cells. J. Immunol. 157:343.
49. Nishijima, I., T. Nakahata, Y. Hirabayashi, T. Inoue, H. Kurata, A. Miyajima, N. Hayashi, Y. Iwakura, K. Arai, and T. Yokota. 1995. A human GM-CSF receptor expressed in transgenic mice stimulates proliferation and differentiation of hemopoietic progenitors to all lineages in response to human GM-CSF. Mol. Biol. Cell 6:497.
50. Galli, S. J., A. Iemura, D. S. Garlick, C. Gamba-Vitalo, K. M. Zsebo, and R. G. Andrews. 1993. Reversible expansion of primate mast cell populations in vivo by stem cell factor. J. Clin. Invest. 91:148.
51. Costa, J. J., G. D. Demetri, T. J. Harrist, A. M. Dvorak, D. F. Hayes, E. A. Merica, D. M. Menchaca, A. J. Gringeri, L. B. Schwartz, and S. J. Galli. 1996. Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J. Exp. Med. 183:2681.
52. Bischoff, S. C., and C. A. Dahinden. 1992. c-kit ligand: a unique potentiator of mediator release by human lung mast cells. J. Exp. Med. 175:237.
53. Columbo, M., E. M. Horowitz, L. M. Botana, D. W. MacGlashan, Jr., B. S. Bochner, S. Gillis, K. M. Zsebo, S. J. Galli, and L. M. Lichtenstein. 1992. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J. Immunol. 149:599.
54. Lukacs, N. W., S. L. Kunkel, R. M. Strieter, H. L. Evanoff, R. G. Kunkel, M. L. Key, and D. D. Taub. 1996. The role of stem cell factor (c-kit ligand) and inflammatory cytokines in pulmonary mast cell activation. Blood 87:2262.
55. Hjertson, M., C. Sundström, S. D. Lyman, K. Nilsson, and G. Nilsson. 1996. Stem cell factor, but not flt3 ligand, induces differentiation and activation of human mast cells. Exp. Hermatol. 24:748.
56. Sperr, W. R., K. Czerwenka, G. Mundigler, M. R. Müller, H. Semper, G. Klappacher, H. D. Glogar, K. Lechner, and P. Valent. 1993. Specific activation of human mast cells by the ligand for c-kit: comparison between lung, uterus and heart mast cells. Int. Arch. Allergy Immunol. 102:170.
57. Undem, B. J., L. M. Lichtenstein, W. C. Hubbard, S. Meeker, and J. L. Ellis. 1994. Recombinant stem cell factor-induced mast cell activation and smooth muscle contraction in human bronchi. Am. J. Respir. Cell Mol. Biol. 11:646.
58. Hill, P. B., A. J. MacDonald, E. M. Thornton, G. G. J. Newlands, S. J. Galli, and H. R. P. Miller. 1996. Stem cell factor enhances immunoglobulin E-dependent mediator release from cultured rat bone marrow-derived mast cells: activation of previously unresponsive cells demonstrated by a novel ELISPOT assay. Immunology 87:326.
59. Koike, T., K. Hirai, Y. Morita, and Y. Nozawa. 1993. Stem cell factor-induced signal transduction in rat mast cells: activation of phospholipase D but not phosphoinositide-specific phospholipase C in c-kit receptor stimulation. J. Immunol. 151:359.
60. TC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J. Histochem. Cytochem. 37:1509.
61. Mayrhoter, G., S. J. Gadd, L. D. Spargo, and L. K. Ashman. 1987. Specificity of a mouse monoclonal antibody raised against acute myeloid leukaemia cells for mast cells in human mucosal and connective tissues. Immunol. Cell Biol. 65:241.
62. Lerner, N. B., K. H. Nocka, S. R. Cole, F. H. Qiu, A. Strife, L. K. Ashman, and P. Besmer. 1991. Monoclonal antibody YB5. B8 identifies the human c-kit protein product. Blood 77:1876.
63. Irani, A. A., S. S. Craig, G. Nilsson, T. Ishizaka, and L. B. Schwartz. 1992. Characterization of human mast cells developed in vitro from fetal liver cells cocultured with murine 3T3 libroblasts. Immunology 77:136.
64. Shimizu, Y. J., L. K. Ashman, Z. M. Du, and L. B. Schwartz. 1996. Internalization of Kit together with stem cell factor on human fetal liver-derived mast cells: new protein and RNA synthesis is required for reappearance of Kit. J. Immunol. 156:3443.
65. Morstyn, G., S. Brown, M. Gordon, J. Crawford, G. Demitri, W. Rich, B. McGuire, M. A. Foote, and I. McNiece. 1994. Stem cell factor is a potent synergistic factor in hematopoiesis. Oncology 51:205.
66. Tsai, M., L. S. Shih, G. F. Newlands, T. Takeishi, K. E. Langley, K. M. Zsebo, H. R. Miller, E. N. Geissler, and S. J. Galli. 1991. The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo: analysis by anatomical distribution, histochemistry, and protease phenotype. J. Exp. Med. 174:125.
67. Schwartz, L. B., K. Sakai, T. R. Bradford, S. L. Ren, B. Zweiman, A. S. Worobec, and D. D. Metcalfe. 1995. The a form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J. Clin. Invest. 96:2702.
68. Schwartz, L. B., T. R. Bradford, C. Rouse, A.-M. Irani, G. Rasp, J. K. Van der Zwan, and P.-W. G. Van Der Linden. 1994. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J. Clin. Immunol. 14:190.